Lexology January 4, 2023
McKee Voorhees & Sease PLC

Artificial intelligence (AI) technology is increasingly being used in the healthcare field, and the US Food and Drug Administration (FDA) plays a crucial role in regulating these applications. Below, we examine the different ways that the FDA regulates AI technology in healthcare and look at some of the challenges and opportunities presented by this rapidly evolving field.

To understand how the FDA regulates AI technology, it’s important to first understand the agency’s definition of a “device”, which is a product-by-product determination, based on the intended use.

According to the Federal Food, Drug, and Cosmetic Act (FDCA), a device is “an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part, or...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Digital Health, FDA, Govt Agencies, Medical Devices, Regulations, Technology
Why Anthropic’s Model Context Protocol Is A Big Step In The Evolution Of AI Agents
Two years on, ChatGPT has yet to change our lives
77% of COOs Using GenAI Report Positive ROI, With Customized Tools Leading the Way
Anthropic's Claude: The AI Junior Employee Transforming Business
AI Teaches Surgery; AI Quality Registry; AI Matches Patients With Trials

Share This Article